Last week the focus was on hot hemp and this week it’s cool cannabinoids. From California’s Creo becoming the first company to achieve demo scale production of rare cannabinoid CBGA in partnership with Genomatica, to Amyris’s expansion of consumer brands by launching a new range of Terasana products using cannabinoids, we dive into what is […]
In California, Creo, an ingredient company with a proprietary platform for producing natural rare cannabinoids without the cannabis plant, has produced cannabigerol (CBG) and cannabigerolic acid (CBGA) through fermentation at 12,500-liter scale, with performance matching or exceeding expectations. Creo is the first fermentation-based cannabinoid company to successfully produce finished CBGA. Rare cannabinoids such as CBG […]
In California, Amyris, Inc. will expand its portfolio of consumer brands by launching a new range of Terasana branded clean beauty products focused on sustainably sourced natural cannabinoids, enabled by its proprietary Lab-to-Market synthetic biology platform, which has a track record of developing and producing platform molecules from naturally sourced sugarcane and a sustainable fermentation […]
We’ve covered beef without the cow, pork without the pig, but what about plants without the plant? That’s what BioMediCan is tackling – technically they aren’t creating a plant without a plant, but they are creating a plant compound, cannabinoids, without cannabis plants, skipping the growing, the sunlight, the watering, the harvesting, and all those […]
While Cheech and Chong now say that marijuana’s coolness is gone, cannabinoids on the other hand are taking off like crazy and Lygos is pushing the gas pedal to the max to scale up and commercialize cannabinoids. In California comes the hot news that Lygos, who you may know for their sugar converting advanced biotech […]
In California, Amyris successfully shipped the first cannabinoid to its partner, LAVVAN. These ingredients are produced with Amyris’s fermentation technology platform which allows Amyris to scale ingredients that are rarer within the cannabis plant, and difficult and extremely expensive to extract in quantity. Amyris is also well on its way to the shipment of a […]
In California, Amyris announced that it has signed a binding term sheet for a planned cannabinoid development, licensing and commercialization partnership valued at up to $255 million (not including significant royalties once the products are commercialized) with a confidential partner. The $255 million in payments include an upfront payment and the remainder are linked to milestones […]
